Prospective associations of B-type natriuretic peptide with markers of left ventricular function in individuals with and without type 2 diabetes: An 8-year follow-up of the Hoorn Study

Diabetes Care

Volumn 35, Issue 12, 2012, Pages 2510-2514

  Kroon, Maria H ^a   Van Den Hurk, Katja ^a   Alssema, Marjan ^a   Kamp, Otto ^a   Stehouwer, Coen D A ^b   Henry, Ronald M A ^b   Diamant, Michaela ^a   Boomsma, Frans ^c   Nijpels, Giel ^a   Paulus, Walter J ^a   Dekker, Jacqueline M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

AGED; ARTICLE; COHORT ANALYSIS; DETERIORATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT ATRIUM VOLUME; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEMODYNAMIC PARAMETERS; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PREDICTIVE VALUE; RATIO OF EARLY DIASTOLIC LEFT VENTRICULAR INFLOW VELOCITY TO EARLY DIASTOLIC LENGTHENING VELOCITY;

AGED; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; VENTRICULAR FUNCTION, LEFT;

EID: 84869783570     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-1959     Document Type: Article

References (23)

1. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974;34:29-34
2. Liew D, Schneider H, D'Agostino J, Shaw J, Krum H. Utility of B-type natriuretic peptide as screen for ventricular dysfunction in patients with diabetes: response to Epshteyn et al. Diabetes Care 2004;27:848-849; author reply 848-849
3. Greenberg B. Pre-clinical diastolic dysfunction in diabetic patients: where do we go from here? J Am Coll Cardiol 2010;55: 306-308
4. Diamant M, Lamb HJ, Groeneveld Y, et al. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with wellcontrolled type 2 diabetes mellitus. J Am Coll Cardiol 2003;42:328-335 (Pubitemid 36851426)
5. Djoussé L, Driver JA, Gaziano JM. Relation between modifiable lifestyle factors and lifetime risk of heart failure. JAMA 2009; 302:394-400
6. Wilkins MR, Redondo J, Brown LA. The natriuretic-peptide family. Lancet 1997; 349:1307-1310 (Pubitemid 27192482)
7. Maisel AS, McCord J, Nowak RM, et al.; Breathing Not Properly Multinational Study Investigators. Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results fromthe Breathing Not Properly Multinational Study. J Am Coll Cardiol 2003;41:2010-2017 (Pubitemid 36677124)
8. Paulus WJ, Tschöpe C, Sanderson JE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007;28:2539-2550 (Pubitemid 47614269)
9. Takahashi T, Nakamura M, Onoda T, et al. Predictive value of plasma B-type natriuretic peptide for ischemic stroke: a community-based longitudinal study. Atherosclerosis 2009;207:298-303
10. Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 2004;350:655-663 (Pubitemid 38364624)
11. van den Hurk K, Alssema M, Kamp O, et al. Slightly elevated B-type natriuretic peptide levels in a non-heart failure range indicate a worse left ventricular diastolic function in individuals with, as compared with individuals without, type 2 diabetes: the Hoorn Study. Eur J Heart Fail 2010; 12:958-965
12. Henry RM, Kostense PJ, Spijkerman AM, et al.; Hoorn Study. Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study. Circulation 2003;107:2089-2095 (Pubitemid 36532189)
13. Boomsma F, Deinum J, van denMeiracker AH. Relationship between natriuretic peptide concentrations in plasma and posture during blood sampling. Clin Chem 2001; 47:963-965 (Pubitemid 32398060)
14. Henry RM, Kamp O, Kostense PJ, et al.; Hoorn study. Left ventricular mass increases with deteriorating glucose tolerance, especially in women: independence of increased arterial stiffness or decreased flow-mediated dilation: the Hoorn study. Diabetes Care 2004;27:522-529 (Pubitemid 38174082)
15. Levey AS, Coresh J, Greene T, et al.; Chronic Kidney Disease Epidemiology Collaboration. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007;53:766-772 (Pubitemid 46580250)
16. World Health Organization and International Diabetes Federation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Geneva, Switzerland, WHO Document Production Services, 2006
17. Prineas RJ, Crow RS, Blackburn H. Cardiovascular survey methods. WHO Monograph Series No 56. Geneva, World Health Organization, 1968
18. Goetze JP, Mogelvang R, Maage L, et al. Plasma pro-B-type natriuretic peptide in the general population: screening for left ventricular hypertrophy and systolic dysfunction. Eur Heart J 2006;27:3004-3010 (Pubitemid 44950445)
19. Epshteyn V, Morrison K, Krishnaswamy P, et al. Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes. Diabetes Care 2003;26:2081-2087 (Pubitemid 41184256)
20. Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 2005;293:1609-1616 (Pubitemid 40471791)
21. Wang TJ, Larson MG, Levy D, et al. Impact of obesity on plasma natriuretic peptide levels. Circulation 2004;109:594-600 (Pubitemid 38198866)
22. Das SR, Drazner MH, Dries DL, et al. Impact of body mass and body composition on circulating levels of natriuretic peptides: results from the Dallas Heart Study. Circulation 2005;112:2163-2168 (Pubitemid 41475811)
23. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol 2007;50:2357-2368 (Pubitemid 50011582)